1.
Malataras P, Pallikarakis N. Spin-off use of adverse events data: why and how. The case of FDA’s MAUDE. GlobalCE [Internet]. 2018 Oct. 13 [cited 2022 Aug. 15];1(1):9-23. Available from: https://globalce.org/index.php/GlobalCE/article/view/32